Galderma Investigational Site 8242

Brooklyn, New York 11203-2012

0 studies enrolling now · 3 studies all time

What they study most

Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed